Vitamin D and hypertension: Prospective study and meta-Analysis

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Qi, Dan ^a   Nie, Xiao Lu ^a   Wu, Shouling ^b   Cai, Jun ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; REVIEW; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; META ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR;

HUMANS; HYPERTENSION; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D;

EID: 85016633249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0174298     Document Type: Review

References (43)

1. Holick MF (2005) Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 98: 1024-1027https://doi.org/10.1097/01.SMJ.0000140865.32054.DB PMID: 16295817.
2. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266-281. https://doi.org/10.1056/NEJMra070553 PMID: 17634462.
3. Holick MF, Chen TC (2008) Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 87: 1080s-1086s. PMID: 18400738.
4. Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103: 204-205. https://doi.org/10.1016/j.jsbmb.2006.12.071 PMID: 17234402.
5. Burgaz A, Orsini N, Larsson SC, Wolk A (2011) Blood 25-hydroxyvitamin D concentration and hypertension: A meta-Analysis. J Hypertens 29: 636-645. https://doi.org/10.1097/HJH.0b013e32834320f9 PMID: 21191311.
6. Sakamoto R, Jaceldo-Siegl K, Haddad E, Oda K, Fraser GE, Tonstad S (2013) Relationship of vitamin D levels to blood pressure in a biethnic population. Nutr Metab Cardiovasc Dis 23: 776-784. https://doi.org/10.1016/j.numecd.2012.04.014 PMID: 22770642.
7. van Ballegooijen AJ, Kestenbaum B, Sachs MC, de Boer IH, Siscovick DS, Hoofnagle AN, et al. (2014) Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi- Ethnic Study of Atherosclerosis). J Am Coll Cardiol 63: 1214-1222. https://doi.org/10.1016/j.jacc.2014.01.012 PMID: 24480627.
8. Vaidya A, Williams JS (2012) The relationship between vitamin D and the renin-Angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 61: 450-458. https://doi.org/10.1016/j.metabol.2011.09.007 PMID: 22075270.
9. Weng S, Sprague JE, Oh J, Riek AE, Chin K, Garcia M, et al. (2013) Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. Plos One 8: E54625. https://doi.org/10.1371/journal.pone.0054625 PMID: 23349943.
10. Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD (2013) A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr 52: 1771-1779. https://doi.org/10.1007/s00394-012-0480-8 PMID: 23262750.
11. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069. https://doi.org/10.1161/HYPERTENSIONAHA.107.087288 PMID: 17372031.
12. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M, et al. (2012) Vitamin D status and changes in cardiovascular risk factors: A prospective study of a general population. Cardiology 123: 62-70. https://doi.org/10.1159/000341277 PMID: 22986625.
13. Chien KL, Hsu HC, Chen PC, Lin HJ, Su TC, Chen MF, et al. (2015) Total 25-hydroxyvitamin D concentration as a predictor for all-cause death and cardiovascular event risk among ethnic Chinese adults: A cohort study in a Taiwan community. Plos One 10.
14. Griffin FC, Gadegbeku CA, Sowers MR (2011) Vitamin D and subsequent systolic hypertension among women. Am J Hypertens 24: 316-321. https://doi.org/10.1038/ajh.2010.226 PMID: 21088670.
15. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106: 963-968. https://doi.org/10.1016/j.amjcard.2010.05.027 PMID: 20854958.
16. Forman JP, Curhan GC, Taylor EN (2008) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52: 828-832. https://doi.org/10.1161/HYPERTENSIONAHA.108.117630 PMID: 18838623.
17. Liu X, Cui L, Wang A, Wang X, Song Q, Li S, et al. (2016) Cumulative Exposure to Ideal Cardiovascular Health and Incident Diabetes in a Chinese Population: The Kailuan Study. J Am Heart Assoc 5.
18. Liu X, Shi J, Wang A, Song Q, Huang Z, Zhu C, et al. (2016) Changes in ideal cardiovascular health status and risk of new-onset type 2 diabetes: The Kailuan prospective study. Medicine (Baltimore) 95: E4571.
19. Song Q, Liu X, Zhou W, Wang L, Zheng X, Wang X, et al. (2016) Long Sleep Duration and Risk of Ischemic Stroke and Hemorrhagic Stroke: The Kailuan Prospective Study. Sci Rep 6: 33664. https://doi.org/10.1038/srep33664 PMID: 27633270.
20. Bikle DD (2011) Vitamin D: An ancient hormone. Exp Dermatol 20: 7-13. PMID: 21197695.
21. Holick MF (2003) Vitamin D: A millenium perspective. J Cell Biochem 88: 296-307. https://doi.org/10.1002/jcb.10338 PMID: 12520530.
22. Slominski AT, Kim TK, Li W, Postlethwaite A, Tieu EW, Tang EK, et al. (2015) Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep 5: 14875. https://doi.org/10.1038/srep14875 PMID: 26445902.
23. Slominski A, Kim TK, Zmijewski MA, Janjetovic Z, Li W, Chen J, et al. (2013) Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol 5: 7-19. https://doi.org/10.4161/derm.23938 PMID: 24494038.
24. Slominski AT, Kim TK, Li W, Tuckey RC (2016) Classical and non-classical metabolic transformation of vitamin D in dermal fibroblasts. Exp Dermatol 25: 231-232. https://doi.org/10.1111/exd.12872 PMID: 26440881.
25. Slominski AT, Kim TK, Li W, Yi AK, Postlethwaite A, Tuckey RC (2014) The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J Steroid Biochem Mol Biol 144 PtA: 28-39.
26. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, et al. (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: An ecologic meta-regression analysis. Osteoporos Int 20: 133-140. https://doi.org/10.1007/s00198-008-0626-y PMID: 18458986.
27. Bell C (1998) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 31: 719.
28. Klag MJ, Whelton PK, Coresh J, Grim CE, Kuller LH (1991) The association of skin color with blood pressure in US blacks with low socioeconomic status. Jama 265: 599-602. PMID: 1987409.
29. Woodhouse PR, Khaw KT, Plummer M (1993) Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J Hypertens 11: 1267-1274. PMID: 8301109.
30. Chan R, Chan D, Woo J, Ohlsson C, Mellstrom D, Kwok T, et al. (2012) Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens 26: 20-27. https://doi.org/10.1038/jhh.2010.126 PMID: 21248778.
31. Dorjgochoo T, Ou Shu X, Xiang YB, Yang G, Cai Q, Li H, et al. (2012) Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies. Br J Nutr 108: 449-458. https://doi.org/10.1017/S0007114511005745 PMID: 22365135.
32. Li L, Yin X, Yao C, Zhu X, Wu X (2012) Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population. Plos One 7: E43344. https://doi.org/10.1371/journal.pone.0043344 PMID: 22937036.
33. Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, MacDonald TM, et al. (2014) Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: Randomized, controlled trial. Hypertension 63: 706-712. https://doi.org/10.1161/HYPERTENSIONAHA.113.02177 PMID: 24420547.
34. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, et al. (2008) Effect of calcium and vitamin D supplementation on blood pressure: The Women's Health Initiative Randomized Trial. Hypertension 52: 847-855. https://doi.org/10.1161/HYPERTENSIONAHA.108.114991 PMID: 18824662.
35. Li YC (2003) Vitamin D regulation of the renin-Angiotensin system. J Cell Biochem 88: 327-331. https://doi.org/10.1002/jcb.10343 PMID: 12520534.
36. Tare M, Emmett SJ, Coleman HA, Skordilis C, Eyles DW, Morley R, et al. (2011) Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 589: 4777-4786. https://doi.org/10.1113/jphysiol.2011.214726 PMID: 21807617.
37. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM (2010) Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 299: H1226-H1234. https://doi.org/10.1152/ajpheart.00288.2010 PMID: 20693391.
38. Liu NQ, Ouyang Y, Bulut Y, Lagishetty V, Chan SY, Hollis BW, et al. (2013) Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology 154: 2270-2280. https://doi.org/10.1210/en.2012-2270 PMID: 23677931.
39. Ke L, Ho J, Feng J, Mpofu E, Dibley MJ, Feng X, et al. (2014) Modifiable risk factors including sunlight exposure and fish consumption are associated with risk of hypertension in a large representative population from Macau. J Steroid Biochem Mol Biol 144 PtA: 152-155.
40. Simpson RU, Hershey SH, Nibbelink KA (2007) Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103: 521-524. https://doi.org/10.1016/j.jsbmb.2006.12.098 PMID: 17275289.
41. Abbasi F, Feldman D, Caulfield MP, Hantash FM, Reaven GM (2015) Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension. Am J Hypertens 28: 266-272. https://doi.org/10.1093/ajh/hpu136 PMID: 25138785.
42. Kamycheva E, Jorde R, Figenschau Y, Haug E (2007) Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J Endocrinol Invest 30: 126-132. https://doi.org/10.1007/BF03347410 PMID: 17392602.
43. Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, et al. (2012) Aldosterone and parathyroid hormone: A precarious couple for cardiovascular disease. Cardiovasc Res 94: 10-19. https://doi.org/10.1093/cvr/cvs092 PMID: 22334595.